Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CPMD Stock Summary
In the News
CPMD Financial details
Company Rating
Sell
Market Cap
4.73M
Income
-7.5M
Revenue
24.95K
Book val./share
-0.07
Cash/share
-0.02
Dividend
-
Dividend %
-
Employees
6
Optionable
No
Shortable
Yes
Earnings
22 Sep 2023
P/E
-0.03
Forward P/E
-
PEG
0
P/S
11.95
P/B
-0.01
P/C
-0.73
P/FCF
-0.2
Quick Ratio
-0.28
Current Ratio
-
Debt / Equity
-0.8
LT Debt / Equity
-0.27
-
-
EPS (TTM)
-0.03
EPS next Y
-
EPS next Q
-
EPS this Y
-71.14%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-69.84%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-145%
ROE
39%
ROC
0.36%
Gross Margin
40%
Oper. Margin
-21978%
Profit Margin
-30039%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
7.0E-4-0.0279
52W High
-
52W Low
-
RSI
49.58
Rel Volume
0.15
Avg Volume
2.68M
Volume
406.2K
Perf Week
-14.71%
Perf Month
11.54%
Perf Quarter
107.14%
Perf Half Y
81.25%
-
-
-
-
Beta
-1190.54
-
-
Volatility
0%, 0%
Prev Close
-3.33%
Price
0.0145
Change
20.83%
CPMD Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -0.17 | -0.8 | -0.55 | -0.14 | -0.04 | |
Operating cash flow per share | -0.05 | -0.12 | -0.01 | -0.03 | -0.01 | |
Free cash flow per share | -0.05 | -0.12 | -0.01 | -0.03 | -0.01 | |
Cash per share | 0.03 | 0.04 | 0.01 | 0 | 0 | |
Book value per share | -0.02 | 0.16 | -0.22 | -0.17 | -0.08 | |
Tangible book value per share | -0.46 | -0.11 | -0.22 | -0.17 | -0.08 | |
Share holders equity per share | -0.02 | 0.16 | -0.22 | -0.17 | -0.08 | |
Interest debt per share | 0.63 | 0.44 | 0.3 | 0.14 | 0.08 | |
Market cap | 30.54M | 39.28M | 19.94M | 967.19K | 2.11M | |
Enterprise value | 39.27M | 48.56M | 29.61M | 9.96M | 16.63M | |
P/E ratio | -9.87 | -1.58 | -0.9 | -0.09 | -0.25 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -32.45 | -10.35 | -35.39 | -0.4 | -1.46 | |
PFCF ratio | -32.45 | -10.22 | -35.39 | -0.4 | -1.35 | |
P/B Ratio | -106.66 | 8.09 | -2.27 | -0.07 | -0.12 | |
PTB ratio | -106.66 | 8.09 | -2.27 | -0.07 | -0.12 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -73.73 | -17.03 | -6.57 | -3.81 | -3.68 | |
EV to operating cash flow | -41.73 | -12.8 | -52.54 | -4.12 | -11.48 | |
EV to free cash flow | -41.73 | -12.64 | -52.54 | -4.11 | -10.63 | |
Earnings yield | -0.1 | -0.63 | -1.11 | -10.69 | -4.04 | |
Free cash flow yield | -0.03 | -0.1 | -0.03 | -2.5 | -0.74 | |
Debt to equity | -32.14 | 1.91 | -1.14 | -0.7 | -0.84 | |
Debt to assets | 0.91 | 0.58 | 1.14 | 78.89 | 2.68 | |
Net debt to EBITDA | -16.4 | -3.25 | -2.14 | -3.44 | -3.22 | |
Current ratio | 0.1 | 0.49 | 0.03 | 0 | 0.01 | |
Interest coverage | -0.45 | -3.57 | -6.32 | -1.99 | -2.28 | |
Income quality | 0.3 | 0.19 | 0.03 | 0.27 | 0.17 | |
Dividend Yield | 0 | 0.07 | 0 | 0 | 0 | |
Payout ratio | 0 | -0.11 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.79 | 0.51 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0.01 | 0 | 0 | 0.08 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | -0.36 | 0 | -2.31 | -0.39 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.25 | 1.67 | 1.63 | 0.73 | 0.27 | |
ROIC | -0.18 | -1.38 | -13.47 | 0.9 | -2.47 | |
Return on tangible assets | -1.43 | -3.19 | -2.54 | -90.44 | -1.58 | |
Graham Net | -0.55 | -0.32 | -0.42 | -0.17 | -0.11 | |
Working capital | -5.36M | -2.02M | -17.08M | -13.01M | -17.07M | |
Tangible asset value | -8.22M | -3.35M | -8.8M | -12.93M | -17.34M | |
Net current asset value | -9.79M | -9.23M | -17.08M | -13.01M | -22.66M | |
Invested capital | -32.14 | 1.91 | -1.14 | -0.7 | -0.84 | |
Average receivables | 0 | 14.18K | 14.46K | 1.16K | 12.51K | |
Average payables | 685.37K | 834.53K | 1.68M | 2.79M | 5.01M | |
Average inventory | 0 | -14.18K | -14.46K | -1.16K | 33.38K | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 2.55K | 6.95K | 79.52K | 8.52K | |
Days of inventory on hand | 0 | -80.22 | -1.57 | -45 | 84.82 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0.14 | 0.05 | 0 | 0.04 | |
Inventory turnover | 0 | -4.55 | -233.22 | -8.11 | 4.3 | |
ROE | 10.81 | -5.13 | 2.52 | 0.8 | 0.49 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -0.01 | -0.01 | 0 | -0.01 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | -0.02 | |
Book value per share | -0.06 | -0.06 | -0.06 | -0.07 | -0.07 | |
Tangible book value per share | -0.06 | -0.06 | -0.06 | -0.07 | -0.07 | |
Share holders equity per share | -0.06 | -0.06 | -0.06 | -0.07 | -0.07 | |
Interest debt per share | 0.06 | 0.06 | 0.05 | 0.05 | 0.06 | |
Market cap | 3.35M | 2.74M | 2.64M | 2.7M | 4.13M | |
Enterprise value | 17.6M | 17.26M | 17.76M | 18.5M | 26.39M | |
P/E ratio | -0.41 | -0.19 | -0.47 | -0.36 | -1.83 | |
Price to sales ratio | 0 | 109.8 | 0 | 0 | 0 | |
POCF ratio | -9.9 | -6.45 | -4.31 | -5.59 | 33.35 | |
PFCF ratio | -8.71 | -6.32 | -4.3 | -4.85 | 34.52 | |
P/B Ratio | -0.22 | -0.16 | -0.14 | -0.13 | -0.2 | |
PTB ratio | -0.22 | -0.16 | -0.14 | -0.13 | -0.2 | |
EV to sales | 0 | 691.77 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -34.35 | -6.33 | -27.45 | -22.59 | -57.93 | |
EV to operating cash flow | -51.99 | -40.67 | -29.03 | -38.37 | 213.02 | |
EV to free cash flow | -45.75 | -39.81 | -28.99 | -33.27 | 220.46 | |
Earnings yield | -0.61 | -1.33 | -0.54 | -0.7 | -0.14 | |
Free cash flow yield | -0.11 | -0.16 | -0.23 | -0.21 | 0.03 | |
Debt to equity | -0.95 | -0.84 | -0.83 | -0.79 | -0.8 | |
Debt to assets | 2.63 | 2.68 | 2.88 | 2.98 | 3.2 | |
Net debt to EBITDA | -27.81 | -5.32 | -23.38 | -19.3 | -48.86 | |
Current ratio | 0.01 | 0.01 | 0.01 | 0 | 0 | |
Interest coverage | -1.33 | -3.78 | -1.57 | -2.51 | -1.88 | |
Income quality | 0.26 | 0.12 | 0.43 | 0.26 | -0.22 | |
Dividend Yield | 0 | 0.07 | 0 | 0 | 0 | |
Payout ratio | 0 | -0.05 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 125.01 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.14 | 0.02 | 0 | 0.15 | -0.03 | |
Capex to revenue | 0 | -0.37 | 0 | 0 | 0 | |
Capex to depreciation | -1.99 | -0.12 | -0.15 | -12.09 | -0.02 | |
Stock based compensation to revenue | 0 | 1.81 | 0 | 0 | 0 | |
Graham number | 0.11 | 0.14 | 0.08 | 0.1 | 0.05 | |
ROIC | -0.19 | -1.55 | -0.38 | -0.72 | -0.67 | |
Return on tangible assets | -0.38 | -0.67 | -0.27 | -0.35 | -0.11 | |
Graham Net | -0.08 | -0.08 | -0.08 | -0.08 | -0.1 | |
Working capital | -14.83M | -17.07M | -17.73M | -19.61M | -20.17M | |
Tangible asset value | -14.98M | -17.34M | -18.21M | -20.14M | -20.63M | |
Net current asset value | -20.3M | -22.66M | -23.38M | -25.42M | -25.73M | |
Invested capital | -0.95 | -0.84 | -0.83 | -0.79 | -0.8 | |
Average receivables | 15.26K | 20.13K | 26.43K | 35.94K | 48.29K | |
Average payables | 4.21M | 5.62M | 7.03M | 7.47M | 7.77M | |
Average inventory | 29.11K | 70.14K | 19.46K | -35.94K | 2.82M | |
Days sales outstanding | 0 | 83.86 | 0 | 0 | 0 | |
Days payables outstanding | 128.81K | 49.65K | 249.15K | 69.94M | 58.29M | |
Days of inventory on hand | 2.13K | 494.39 | -1.03K | -380.35K | 42.68M | |
Receivables turnover | 0 | 1.07 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0.04 | 0.18 | -0.09 | 0 | 0 | |
ROE | 0.14 | 0.21 | 0.08 | 0.09 | 0.03 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
CPMD Frequently Asked Questions
What is CannaPharmaRX, Inc. stock symbol ?
CannaPharmaRX, Inc. is a CA stock , located in Calgary of Ab and trading under the symbol CPMD
What is CannaPharmaRX, Inc. stock quote today ?
CannaPharmaRX, Inc. stock price is $0.0145 today.
Is CannaPharmaRX, Inc. stock public?
Yes, CannaPharmaRX, Inc. is a publicly traded company.